Schreiber Lab

The Malaria Therapeutics Response Portal results from efforts to discover new antimalarial targets targeting multiple stages of Plasmodium parasites and acting by novel mechanisms of action. The data result from primary and secondary screens of a diverse collection of 100,000 compounds having three-dimensional topographic features derived from...

Using multiplex-cytological (MC) and gene-expression (GE) profiling assays, we assembled a reference dataset of profiles for structurally and stereochemically diverse diversity-oriented synthesis (DOS)-derived compounds (18,000-20,000), chemically diverse Molecular Libraries Program (MLP) compounds with biologically diverse performance identified...

After screening a library of over 100,000 small molecules, researchers from the Broad Institute of MIT and Harvard have identified compounds that act on a novel target in the malaria parasite, Plasmodium falciparum.The study resulted in the publication of a paper (available online September 7 inNature] and an open, data-rich resource for the malaria research community called theMalaria Therapeutics Response Portal(MTRP).

The Cancer Therapeutics Response Portal (CTRP) links genetic, lineage, and other cellular features of cancer cell lines to small-molecule sensitivity with the goal of accelerating discovery of patient-matched cancer therapeutics. CTRP can be mined to develop insights into small-molecule mechanisms of action and novel therapeutic hypotheses, and...